Vulcur Medtech
VulCur Medtech is developing a medical device for treating chronic wounds. Chronic wounds result in an amputation every 30 seconds and is accounting for ~5.5% of the total healthcare expenses. These wounds are closely linked to diabetes and affect 6.5M Americans (2% of the total population).